Announcements

MDPI will be attending the 11th Congress of the European Academy of Neurology, which will be held in Helsinki, Finland, from 21 to 24 June 2025. The EAN Congress 2025 is organized by the European Academy of Neurology. Its exciting overarching theme of neurology within society sets the scene for an unforgettable congress and is highly relevant to our practice as neurologists, given our crucial role as clinicians—and in many cases neuroscientists—in addressing the huge burden of neurological disorders. To have an impact, we must work with many other stakeholders and specialties, and we look forward to welcoming many of them to the home of neurology in 2025. As usual, the overarching theme will serve as a common thread throughout all the invited content of our congress, from workshops to plenary sessions.

The following MDPI journals will be represented:

• Brain Sciences;
• JCM;
• CTN;
• Neurology International;
• Neuroglia;
• Cells;
• Diagnostics;
• Neurosci;
• Psychiatry International;
• Antioxidants;
• Biomolecules;
• Genes;
• IJTM;
• Vaccines.

If you plan to attend the conference, please visit our booth #E48. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.ean.org/congress2025.

Recently, Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held the Editor-in-Chief and Section Editors-in-Chief Annual Meeting on 17 February 2025, 8:30–10:00 CET. This significant event was hosted by the Editor-in-Chief, Prof. Dr. Kent Doi, and fifteen Section Editors-in-Chief were in attendance, each bringing their unique expertise and insights. We are grateful for the support of all attendees. This meeting presented an opportunity for us to come together to review the journal’s past developments and look forward to a better year.

We reviewed and discussed the following topics with the attendees:

• An overview of the journal’s performance in 2024;
• The current Section status, a new Section established, and hot topic data;
• Marketing activities, virtual conferences, society cooperation, journal awards, and social media promotion.

The following information was covered in the discussion:

• Currently, the publication and citation data of the journal are satisfactory. In 2025, with the aim of enhancing the journal’s impact factor, the Editorial Board Members put forward suggestions regarding, for example, the types of submissions, the peer-review process, and setting goals for different Sections;
• Marketing promotion activities were discussed. Members showed their interest in the upcoming International Online Conference on Clinical Medicine (IOCCM) 2025. The registration for attendees is completely free of charge. We are calling for speakers and topic suggestions from attendees;
• The Editorial Board Members gave detailed suggestions on how to strengthen cooperation with societies to increase the exposure of the journal and promote wider scholarly communication.

Attendee list (Sections are ordered alphabetically, in no particular order):

• Prof. Dr. Kent Doi (Editor-in-Chief), Department of Acute Care Medicine, University of Tokyo, Tokyo, Japan;
• Prof. Dr. Luis Garcia-Marcos (“Clinical Pediatrics” Section Editor-in-Chief), Respiratory and Allergy Units, Arrixaca Children’s University Hospital, University of Murcia, Murcia, Spain;
• Dr. Stefanos Bonovas (“Clinical Research Methods” Section Editor-in-Chief), ¹ Department of Biomedical Sciences, Humanitas University, Milan, Italy; ² IRCCS Humanitas Research Hospital, Milan, Italy;
• Prof. Dr. Gregory Y. H. Lip (“Cardiology” Section Editor-in-Chief), ¹ Price-Evans Professor of Cardiovascular Medicine, University of Liverpool, Liverpool, UK; ² Distinguished Professor, Aalborg University, Aalborg, Denmark;
• Prof. Dr. Mario Plebani (“Clinical Laboratory Medicine” Section Editor-in-Chief), Department of Laboratory Medicine, University-Hospital of Padova, Padova, Italy;
• Prof. Dr. Francisco Guillen-Grima (“Epidemiology & Public Health” Section Editor-in-Chief), ¹ Department of Preventive Medicine, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain; ² Navarra Medical Research Institute (IdiSNA), Pamplona, Spain; ³ Center for Biomedical Research Network Epidemiology and Public Health, Madrid, Spain; ⁴ Department of Health Sciences, Public University of Navarra, Pamplona, Spain;
• Prof. Dr. Michael Christ (“Emergency Medicine” Section Editor-in-Chief), Emergency Department, Luzerner Kantonsspital, Luzern, Switzerland;
• Prof. Dr. Hidekazu Suzuki (“Gastroenterology & Hepatopancreatobiliary Medicine” Section Editor-in-Chief), Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan;
• Dr. Carlo Finelli (“Hematology” Section Editor-in-Chief), ¹ Italian MDS Foundation (FISIM - ETS), Bologna, Italy; ² IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy;
• Prof. Dr. Karim Bendjelid (“Intensive Care” Section Editor-in-Chief), CardioVascular Unit, Intensive Care Division, Geneva University Hospitals, Switzerland;
• Prof. Dr. Robert Flisiak (“Infectous Diseases” Section Editor-in-Chief), Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland;
• Prof. Dr. Icro Maremmani (“Mental Health” Section Editor-in-Chief), Vincent P. Dole Dual Disorder Unit, Institute of Behavioural Sciences, Pisa, Italy;
• Prof. Dr. Alberto Signore (“Nucelar Medicine & Radiology” Section Editor-in-Chief), Department of Surgical-Medical Sciences and Translational Medicine, University of Rome “Sapienza”, Rome, Italy;
• Prof. Dr. Eyal Sheiner (“Obstetrics & Gynecology” Section Editor-in-Chief), Department of Obstetrics and Gynecology, Soroka University Medical Center, Beersheba, Israel;
• Dr. Nicholas David Clement (“Orthopedics” Section Editor-in-Chief), Edinburgh Orthopaedics, Royal Infirmary of Edinburgh, Edinburgh, UK;
• Dr. Sukhwinder Singh Sohal (“Pulmonology” Section Editor-in-Chief), Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, Australia.

The latest official CiteScore (2023 Scopus data) for the Journal of Clinical Medicine is 5.7, ranking 80/636 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.0 (2023), ranking 59/329 (Q1) in the “Medicine, General, and Internal” category. To access more journal statistics, please click here.

Autistic individuals contribute uniquely to society, bringing diverse perspectives, creativity, and innovation. Recognizing and valuing neurodiversity fosters more inclusive communities where individuals with autism can thrive. However, many face challenges in accessing education, employment, healthcare, and social support due to systemic barriers and misconceptions. By strengthening inclusive policies, support networks, and awareness efforts, we can create environments that empower autistic individuals to reach their full potential while ensuring their rights, dignity, and well-being. 

In recognition of the International Day of Autism Awareness, observed annually on 2 April, we celebrate the contributions of autistic individuals and reaffirm our commitment to promoting inclusion and acceptance. The theme for this year’s World Autism Awareness Day, “Advancing Neurodiversity and the UN Sustainable Development Goals (SDGs)”, emphasizes the importance of integrating neurodiversity into global development efforts, ensuring that autistic individuals are included in the pursuit of the SDGs. We highlight a selection of relevant articles, Special Issues, and journals spanning disciplines such as psychology, education, public health, and social sciences. Through the dissemination of research, we aim to deepen understanding, promote acceptance, and encourage practical solutions that enhance the lives of autistic individuals. By fostering awareness and advocacy, we can work toward a more inclusive, supportive, and neurodiverse society.

 Invited speakers:

	Prof. Dr. Marios Adamou, University of Huddersfield, UK Presentation: “Enhancing Adult Autism Diagnostic Pathways: The Role of Clinical Triage in Efficient Service Provision”
	Dr. Andrey Vyshedskiy, Boston University, USA Presentaion: “Fostering Syntactic Language Acquisition in Children with Autism”
	Dr. Roberto Canitano, Univeristy of L’Aquila, Italy Presentation: “Experimental Treatments in ASD”

Feel free to register for this webinar here. 

“Cognitive and Emotional Resilience in Parents with Children with Autism Spectrum Disorder During COVID-19: The Role of Promoting Variables”
by Aziz Sarhani-Robles, Maria Guillot-Valdes, Maria Auxiliadora Robles-Bello and David Sanchez-Teruel
J. Intell. 2025, 13(1), 6; https://doi.org/10.3390/jintelligence13010006 

“International Perspectives on Assistive Technologies for Autism and Intellectual Disabilities: Findings from a Delphi Study”
by Paulina Tsvetkova, Carla Sousa, Daniel Beiderbeck, Aneta M. Kochanowciz, Branislav Gerazov, May Agius, Tomasz Przybyla, Merita Hoxha and Alan H. Tkacyz
Disabilities 2024, 4(4), 1138-1155; https://doi.org/10.3390/disabilities4040071 

“Validity of the Greek Knowledge About Childhood Autism Among Health Workers (KCAHW) Questionnaire”
by Vasiliki Zarokanellou, Alexandros Gyparis, Evridiki Papagiannopoulou and Vassiliki Siafaka
Psychiatry. Int. 2024, 5(4), 962-974; https://doi.org/10.3390/psychiatryint5040066 

“The Feasibility of Whole-Body Vibration Training as an Approach to Improve Health in Autistic Adults”
by Amy Allnutt, Sara Pappa and Michael Nordvall
Disabilities 2024, 4(3), 429-443; https://doi.org/10.3390/disabilities4030027 

“The Association between Autism Spectrum Disorder and Precocious Puberty: Considering Effect Modification by Sex and Neuropsychiatric Comorbidities“
by Yi-Chun Liu, Yin-To Liao, Mei-Hong Wan, Vincent Chin-Huang Chen and Yi-Lung Chen
J. Pers. Med. 2024, 14(6), 632; https://doi.org/10.3390/jpm14060632 

“Epidemiological Study of Autism Spectrum Disorders in Greece for 2021: Nationwide Prevalence in 2–17-Year-Old Children and Regional Disparities”
by Raissa Kouznetsov, Panagiotis Angelopoulos, Spyridon Moulinos, Ioannis Dimakos, Philippos Gourzis and Eleni Jelastopuly
J. Clin. Med. 2023, 12(7), 2510; https://doi.org/10.3390/jcm12072510

“Mental Health, Innovative Therapies and Assessment in Adolescents and Young Adults and Related Contexts” Guest Editors: Prof. Dr. David Sánchez-Teruel and Prof. Dr. Mª Auxiliadora Robles-Bello Submission Deadline: 30 September 2025

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383, Impact Factor 3.0) successfully hosted the 2nd International Electronic Conference on Clinical Medicine from 13 to 15 November 2024. Following the event, we had the pleasure of interviewing Dr. Hamzah Adwan, winner of one of the Best Oral Presentation Awards. Dr. Adwan is based at the Clinic for Radiology and Nuclear Medicine, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.

The following is an interview with Dr. Hamzah Adwan:

Personal and Research Background

1. Could you introduce yourself and share a bit about your research background and briefly describe the key focus and impact of your award-winning paper?
I am a medical doctor and am currently completing my residency in radiology in Frankfurt am Main, Germany. For the past few years, I have been conducting research at the University Hospital of Goethe University Frankfurt, focusing on interventional radiology. I have had the opportunity to present my work at several prestigious conferences and have published numerous studies. My research work has earned several awards and recognitions.
My award-winning paper focused on interventional treatments for liver metastases arising from colorectal cancer, utilizing minimally invasive techniques such as transarterial chemoembolization (TACE) and microwave ablation (MWA). We compared the combination of TACE followed by MWA with MWA alone as a treatment for liver metastases. Our study demonstrated the superiority of the combination therapy, particularly in terms of improved overall survival, significantly longer hepatic progression-free survival, and notably larger ablation zones when compared to the monotherapy group.

Award and Recognition

2. How does it feel to receive this award at the 2nd International Electronic Conference on Clinical Medicine? What do you think made your research stand out among other submissions?
Winning the Best Oral Presentation Award is an incredible feeling! I believe it is crucial to present research in a thorough yet simple way to engage the audience. However, this can be challenging, as the audience often has varying levels of knowledge about the topic. It is essential to ensure that the presentation is clear and accessible to everyone and that is what I tried to do, and it was well received.

3. How do you see this recognition influencing your future research or career?
Receiving such an award and recognition is a great source of motivation for me to continue my research and pursue further studies in my area of interest.

Conference Experience

4. How was your overall experience participating in this conference?
It was a fantastic experience. The conference was excellently organized, featuring a wide range of engaging sessions and topics.

5. Were there any particular sessions, discussions, or networking opportunities that stood out to you?
All the sessions were exceptionally organized and had a significant scientific impact. My favorite sessions were on gastroenterology and hepatopancreatobiliary medicine, as well as oncology and hematology.

6. Did the conference provide you with any valuable feedback or insights that could enhance your research?
Yes, absolutely. I gained valuable insights from the engaging discussions during the sessions, which will be beneficial for my future research.

Future Collaboration and Engagement

7. Do you see potential for collaboration with other researchers or institutions you met at the conference?
Yes, definitely! Conferences provide excellent opportunities to collaborate and network with colleagues from various countries and specialties.

8. Would you be interested in participating in future editions of the 3rd International Online Conference on Clinical Medicine, which is newly named IOCCM2025?
Certainly! I am very interested in participating in the upcoming edition of this conference and am already preparing abstracts for submission.

9. Are there any topics or formats you would like to see included in future conferences?
I would like to see more sessions focused on interventional radiology treatments, as these play a crucial role in managing both oncological and non-oncological diseases, offering minimally invasive procedures with high efficacy and safety.

Final Thoughts

10. What advice would you give to researchers looking to submit their work to this conference?
I strongly urge all colleagues, particularly young researchers, to seize the opportunity to participate in the upcoming conference and showcase their work. This is an incredible chance to present your research to a distinguished audience. There is nothing quite like the experience of sharing your work at such an event and receiving invaluable feedback from fellow researchers!

11. Is there anything else you would like to share about your experience or your future research plans?
I am currently working on several ongoing studies and planning additional research on various aspects of interventional radiology. I am excited to submit these studies for publication in the near future.

Continuing from the success of the 2nd International Electronic Conference on Clinical Medicine, we are delighted to invite you to join the 3rd International Online Conference on Clinical Medicine (IOCCM 2025).

Introduction of IOCCM 2025:

Conference date: 17–19 November 2025
Deadline for abstract submission: 8 August 2025
Deadline for registration: 3 November 2025

Conference chairs:

• Prof. Dr. Emmanuel Andrès;
• Prof. Dr. Kent Doi;
• Prof. Dr. Francisco Guillen-Grima.

For more details, please visit https://sciforum.net/event/IOCCM2025.

For any inquiries regarding the event, please contact ioccm2025@mdpi.com.

Reflecting on the year 2024, we are reminded of the accomplishments that we made and the people who helped make them possible. Journal of Clinical Medicine (JCM, ISSN: 2077-0383) received a 2023 Impact Factor of 3.0 and ranked 59/329 (Q1) in the “Medicine, General & Internal Medicine” category. Our publications have been steadily increasing, and papers published in our journal have been cited frequently. The Editorial Board Members’ support and contributions have been crucial to the journal’s efficient running, whether you were handling Special Issues, assessing manuscripts, or offering quick and expert advice on ethical issues. We therefore would like to recognize the top 5% of Editorial Board Members for their positive and outstanding contributions to editorial activities in the journal. Your dedication and support have kept our publishing quality standards high and have motivated us to enhance the services we deliver to the scientific community.

We hope that this partnership will continue in 2025 and that our combined efforts will strengthen and increase the influence of our journal. The names of the honored Editorial Members are listed below in alphabetical order by first name and Section name:

Tuberculosis is a disease that is both preventable and treatable, significantly affecting people’s health and quality of life worldwide. Every year, we commemorate World Tuberculosis Day to raise public awareness of the devastating health, social, and economic consequences of tuberculosis (TB) and to intensify efforts to end the global TB epidemic. The date signifies the day in 1882 when Dr. Robert Koch announced his discovery of the bacterium responsible for TB, which paved the way for diagnosing and curing this disease. We hope that established journals in the fields of Biology Life Sciences and Medicine & Pharmacology at MDPI, including Pathogens, Microorganisms, Reports, Medical Sciences, Healthcare and Diagnostics will continue to serve as a communication platform for innovative ideas regarding prevention and treatment.

“Impact of Severity of COVID-19 in TB Disease Patients: Experience from an Italian Infectious Disease Referral Hospital”
by Virginia Di Bari, Carlotta Cerva, Raffaella Libertone, Serena Maria Carli, Maria Musso, Delia Goletti, Alessandra Aiello, Antonio Mazzarelli, Angela Cannas, Giulia Matusali, Fabrizio Palmieri, Gina Gualano and on behalf of the TB-INMI Working Group
Infect. Dis. Rep. 2025, 17(1), 11; https://doi.org/10.3390/idr17010011 

“Cigarette Smoking as a Risk Factor for Tuberculosis in Adults: Epidemiology and Aspects of Disease Pathogenesis”
by Charles Feldman, Annette J. Theron, Moloko C. Cholo and Ronald Anderson
Pathogens 2024, 13(2), 151; https://doi.org/10.3390/pathogens13020151 

“Situation Analysis of Early Implementation of Programmatic Management of Tuberculosis Preventive Treatment among Household Contacts of Pulmonary TB Patients in Delhi, India”
by Yasir Alvi, Sairu Philip, Tanu Anand, Palanivel Chinnakali, Farzana Islam, Neeta Singla, Pruthu Thekkur, Ashwani Khanna and BK Vashishat
Trop. Med. Infect. Dis. 2024, 9(1), 24; https://doi.org/10.3390/tropicalmed9010024 

“HLA-DPB1*05:01 and HLA-A*11:01 Is Associated with Adverse Drug Reactions to Isoniazid and Rifampin for Treatment of Latent Tuberculosis Infection in South Korea”
by Bomi Kim, Jungok Kim, Sun-Young Yoon, Hae Suk Cheong, Min-Jung Kwon, Joon-Sup Yeom, Han-Na Kim and Eun-Jeong Joo
Clin. Med. 2024, 13(12), 3563; https://doi.org/10.3390/jcm13123563 

“Pharmacists’ Role in Global TB Elimination: Practices, Pitfalls, and Potential”
by Alina Cernasev, Jonathan Stillo, Jolie Black, Mythili Batchu, Elaina Bell and Cynthia A. Tschampl
Healthcare 2024, 12(11), 1137; https://doi.org/10.3390/healthcare12111137 

“Metabolic Rewiring of Mycobacterium tuberculosis upon Drug Treatment and Antibiotics Resistance”
by Biplab Singha, Sumit Murmu, Tripti Nair, Rahul Singh Rawat, Aditya Kumar Sharma and Vijay Soni
Metabolites 2024, 14(1), 63; https://doi.org/10.3390/metabo14010063 

“Exploring the Impact of Silicosis Incidence on Tuberculosis Mortality and Morbidity: A Multi-Country Study”
by Muayad Albadrani
Med. Sci. 2023, 11(4), 63; https://doi.org/10.3390/medsci11040063

This year, World Down Syndrome Day will be celebrated on 21 March 2025. Each year, approximately 3,000 to 5,000 children are born with this chromosome disorder. In 2025, we call for people around the world to “end the stereotypes”.

Aiming at improving the quality of life of people with Down syndrome and propelling the scientific development in this field, we would like to recommend some related articles, Special Issues, and journals in MDPI as suitable communication platforms for you. We believe that sharing research like this can help raise awareness of Down syndrome.

“When Language Is Not Enough: How to Explain ToM Abilities of Individuals with Williams Syndrome and Down Syndrome”
by Claire Touchet, Régis Pochon and Laure Ibernon
Disabilities 2025, 5(1), 4; https://doi.org/10.3390/disabilities5010004

“Assessing Uveitis Risk following Pediatric Down Syndrome Diagnosis: A TriNetX Database Study”
by Alan Y. Hsu, Yu-Hsun Wang, Chun-Ju Lin, You-Ling Li, Ning-Yi Hsia, Chun-Ting Lai, Hou-Ting Kuo, Huan-Sheng Chen, Yi-Yu Tsai and James Cheng-Chung Wei
Medicina 2024, 60(5), 710; https://doi.org/10.3390/medicina60050710

“Impact of Resistance Training on Body Composition and Physical Function in Individuals with Down Syndrome: A Meta-Analysis”
by Hou-Ting Kuo, Ting-Hsu Lee, Li-An Su, Li-Yun Wu, Ping-Yan Mao and Ciao-Ci Yang
Diagnostics 2024, 14(23), 2620; https://doi.org/10.3390/diagnostics14232620

“The Role of Tau Pathology in Alzheimer’s Disease and Down Syndrome”
by Ann-Charlotte Granholm and Eric D. Hamlett
J. Clin. Med. 2024, 13(5), 1338; https://doi.org/10.3390/jcm13051338

“Astrocytic Alterations and Dysfunction in Down Syndrome: Focus on Neurogenesis, Synaptogenesis, and Neural Circuits Formation”
by Beatrice Uguagliati and Mariagrazia Grilli
Cells 2024, 13(24), 2037; https://doi.org/10.3390/cells13242037

“Lipid Profile, Eating Habit, and Physical Activity in Children with Down Syndrome: A Prospective Study”
by Luca Pecoraro, Melissa Zadra, Francesco Cavallin, Silvana Lauriola, Giorgio Piacentini and Angelo Pietrobelli
Diseases 2024, 12(4), 68; https://doi.org/10.3390/diseases12040068

“Impact of Physical Activity on Autonomy and Quality of Life in Individuals with Down Syndrome: A Systematic Review”
by Antonio Muñoz-Llerena, Laura Ladrón-de-Guevara, Daniel Medina-Rebollo and Virginia Alcaraz-Rodríguez
Healthcare 2024, 12(2), 181; https://doi.org/10.3390/healthcare12020181

“Health Checks for People with Down Syndrome: A Pooled Analysis of Three Randomized Controlled Trials”
by Robert S. Ware, Catherine Franklin, Lyn McPherson and Nicholas G. Lennox
Disabilities 2024, 4(1), 101-110; https://doi.org/10.3390/disabilities4010007

“DNMT3B rs2424913 as a Risk Factor for Congenital Heart Defects in Down Syndrome”
by Dijana Majstorović, Anita Barišić, Ivana Babić Božović, Iva Bilić Čače, Neven Čače, Mauro Štifanić and Jadranka Vraneković
Genes 2023, 14(3), 576; https://doi.org/10.3390/genes14030576

“Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules”
by Lanzillotta, Chiara, and Fabio Di Domenico
Biomolecules 2021, 11(2), 266; https://doi.org/10.3390/biom11020266

“Role of 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation and Cellular Bioenergetics in Human Down Syndrome Fibroblasts”
by Panagaki, Theodora, Elisa B. Randi, and Csaba Szabo
Biomolecules 2020, 10(4), 653; https://doi.org/10.3390/biom10040653

“The Care Economy and Disability Inclusion”	“Fragile X Syndrome and Fragile X Premutation Associated Conditions”
“Physical Activity, Exercise, and Sport in People with Disabilities: Strategies for Health Promotion”	“Cellular and Molecular Alterations in the Down Syndrome Brain: A Starting Point for the Design of Therapeutic Approaches”

Kidneys, like the “purification factory” of the body, filter waste and excess water from the blood. However, nowadays, the incidence of kidney disease is rising and it has become an invisible killer that poses a serious threat to health. We welcome you to read the following highly cited papers published in Journal of Clinical Medicine (JCM, ISSN: 2077-0383) , and hope that these articles can bring new ideas for kidney disease research. In addition, some Special Issues on this topic are currently open for submission.

1. “Pathomechanisms of Diabetic Kidney Disease”
by Satyesh K. Sinha and Susanne B. Nicholas
J. Clin. Med. 2023, 12(23), 7349; https://doi.org/10.3390/jcm12237349
Full text available online: https://www.mdpi.com/2077-0383/12/23/7349

2. “Renal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety”
by Peter Schnuelle
J. Clin. Med. 2023, 12(19), 6424; https://doi.org/10.3390/jcm12196424
Full text available online: https://www.mdpi.com/2077-0383/12/19/6424

3. “Preventing Rejection of the Kidney Transplant”
by Divyanshu Malhotra and Priyanka Jethwani
J. Clin. Med. 2023, 12(18), 5938; https://doi.org/10.3390/jcm12185938 
Full text available online: https://www.mdpi.com/2077-0383/12/18/5938

4. “The Diagnostic and Prognostic Roles Played by Homocysteine and Other Aminothiols in Patients with Chronic Kidney Disease”
by Maria Petrovna Kruglova, Alexander Vladimirovich Ivanov, Anatolij Nikolaevich Fedoseev, Edward Danielevich Virus, Victor Aleksandrovich Stupin, Vladimir Anatolyevich Parfenov, Svetlana Andreevna Titova, Polina Igorevna Lazareva, Aslan Amirkhanovich Kubatiev and Ekaterina Vladimirovna Silina
J. Clin. Med. 2023, 12(17), 5653; https://doi.org/10.3390/jcm12175653
Full text available online: https://www.mdpi.com/2077-0383/12/17/5653

5. “Blood Purification in Patients with Sepsis Associated with Acute Kidney Injury: A Narrative Review”
by Jun Kamei, Masafumi Kanamoto, Yutaka Igarashi, Kodai Suzuki, Kensuke Fujita, Tsukasa Kuwana, Takayuki Ogura, Katsunori Mochizuki, Yuki Banshotani, Hiroyasu Ishikura et al.
J. Clin. Med. 2023, 12(19), 6388; https://doi.org/10.3390/jcm12196388
Full text available online: https://www.mdpi.com/2077-0383/12/19/6388

6. “Sex-Related Aspects in Diabetic Kidney Disease—An Update”
by Ivonne Loeffler and Nadja Ziller
J. Clin. Med. 2023, 12(8), 2834; https://doi.org/10.3390/jcm12082834
Full text available online: https://www.mdpi.com/2077-0383/12/8/2834

7. “Treatment of Acute Kidney Injury: A Review of Current Approaches and Emerging Innovations”
by Christina Tamargo, Mohamad Hanouneh and C. Elena Cervantes
J. Clin. Med. 2024, 13(9), 2455; https://doi.org/10.3390/jcm13092455
Full text available online: https://www.mdpi.com/2077-0383/13/9/2455

8. “Chronic Kidney Disease in the Older Adult Patient with Diabetes”
by Raja Ravender, Maria-Eleni Roumelioti, Darren W. Schmidt, Mark L. Unruh and Christos Argyropoulos
J. Clin. Med. 2024, 13(2), 348; https://doi.org/10.3390/jcm13020348
Full text available online: https://www.mdpi.com/2077-0383/13/2/348

9. “Risk Factors of Chronic Kidney Disease Progression: Between Old and New Concepts”
by Francesca Mallamaci and Giovanni Tripepi
J. Clin. Med. 2024, 13(3), 678; https://doi.org/10.3390/jcm13030678
Full text available online: https://www.mdpi.com/2077-0383/13/3/678

10. “Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets”
by Allison B. Reiss, Berlin Jacob, Aarij Zubair, Ankita Srivastava, Maryann Johnson and Joshua De Leon
J. Clin. Med. 2024, 13(7), 1881; https://doi.org/10.3390/jcm13071881
Full text available online: https://www.mdpi.com/2077-0383/13/7/1881

11. “Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease”
by Didier Sánchez-Ospina, Sebastián Mas-Fontao, Carolina Gracia-Iguacel, Alejandro Avello, Marina González de Rivera, Maddalen Mujika-Marticorena and Emilio Gonzalez-Parra
J. Clin. Med. 2024, 13(5), 1428; https://doi.org/10.3390/jcm13051428
Full text available online: https://www.mdpi.com/2077-0383/13/5/1428

12. “Kidney Stones of Type I vs. Type II Diabetic Patients: Are There Any Differences?”
by Cătălin Pricop, Marius Ivănuță, Mihaela Nikolic and Dragoş Puia
J. Clin. Med. 2024, 13(20), 6110; https://doi.org/10.3390/jcm13206110
Full text available online: https://www.mdpi.com/2077-0383/13/20/6110

Special Issues:
“Challenges and Opportunities in Geriatric Nephrology and Urology” Guest Editor: Prof. Dr. Giulio Romano Submission deadline: 20 May 2025	“Kidney Transplantation: Current Challenges and Future Perspectives” Guest Editors: Dr. Alberto Piana and Dr. Angelo Territo Submission deadline: 20 May 2025
“Targeted Treatment of Kidney Stones” Guest Editors: Prof. Dr. Carmen Gonzalez-Enguita and Dr. Alberto Budía-Alba Submission deadline: 30 June 2025	“Acute Kidney Events in Intensive Care Patients” Guest Editor: Prof. Dr. Kada Klouche Submission deadline: 31 August 2025

We are delighted to share some highly cited papers from the Section “Oncology” that were published in Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2024. You are welcome to read these highly cited papers and find the latest publications through the following link: https://www.mdpi.com/search?journal=jcm&section=500. Additionally, some Special Issues in the “Oncology” Section are currently open for submissions. The following is a list of articles and Special Issues that we believe may interest you:

1. “The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature”
by Francesco Claps, Arianna Biasatti, Luca Di Gianfrancesco, Luca Ongaro, Gianluca Giannarini, Nicola Pavan, Antonio Amodeo, Alchiede Simonato, Alessandro Crestani, Alessia Cimadamore et al.
J. Clin. Med. 2024, 13(15), 4349; https://doi.org/10.3390/jcm13154349
Full text available online: https://www.mdpi.com/2077-0383/13/15/4349

2. “Prostate Cancer Liver Metastasis: An Ominous Metastatic Site in Need of Distinct Management Strategies”
by Audrey Shiner, Rubens Copia Sperandio, Mahdi Naimi and Urban Emmenegger
J. Clin. Med. 2024, 13(3), 734; https://doi.org/10.3390/jcm13030734
Full text available online: https://www.mdpi.com/2077-0383/13/3/734

3. “From the Colon to the Liver: How Gut Microbiota May Influence Colorectal Cancer Metastatic Potential”
by Irene Mignini, Giulia Piccirilli, Linda Galasso, Fabrizio Termite, Giorgio Esposto, Maria Elena Ainora, Antonio Gasbarrini and Maria Assunta Zocco
J. Clin. Med. 2024, 13(2), 420; https://doi.org/10.3390/jcm13020420
Full text available online: https://www.mdpi.com/2077-0383/13/2/420

4. “Proton Pump Inhibitors and Cancer Risk: A Comprehensive Review of Epidemiological and Mechanistic Evidence”
by Ibrahim O. Sawaid and Abraham O. Samson
J. Clin. Med. 2024, 13(7), 1970; https://doi.org/10.3390/jcm13071970
Full text available online: https://www.mdpi.com/2077-0383/13/7/1970

5. “Robotic-Assisted versus Laparoscopic Surgery for Rectal Cancer: An Analysis of Clinical and Financial Outcomes from a Tertiary Referral Center”
by Jasper Max Gebhardt, Neno Werner, Andrea Stroux, Frank Förster, Ioannis Pozios, Claudia Seifarth, Christian Schineis, Benjamin Weixler, Katharina Beyer and Johannes Christian Lauscher
J. Clin. Med. 2024, 13(6), 1795; https://doi.org/10.3390/jcm13061795
Full text available online: https://www.mdpi.com/2077-0383/13/6/1795

6. “Reliability of Ultrasonographic Assessment of Depth of Invasion and Tumor Thickness in Intraoral Mucosa Lesions: A Preliminary Experience”
by Anna Russo, Vittorio Patanè, Luigia Fusco, Lorenzo Faggioni, Ciro Emiliano Boschetti, Mario Santagata, Emanuele Neri, Salvatore Cappabianca and Alfonso Reginelli
J. Clin. Med. 2024, 13(9), 2595; https://doi.org/10.3390/jcm13092595
Full text available online: https://www.mdpi.com/2077-0383/13/9/2595

7. “Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies”
by Chiara Tommasi, Giulia Airò, Fabiana Pratticò, Irene Testi, Matilde Corianò, Benedetta Pellegrino, Nerina Denaro, Laura Demurtas, Mariele Dessì, Sara Murgia et al.
J. Clin. Med. 2024, 13(7), 1873; https://doi.org/10.3390/jcm13071873
Full text available online: https://www.mdpi.com/2077-0383/13/7/1873

8. “Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in the Treatment of Gastric Cancer: Feasibility, Efficacy and Safety—A Systematic Review and Meta-Analysis”
by Francisca Ramalho-Vasconcelos, Raquel Gomes, Raquel Bouça-Machado, Marisa Aral, Jorge Nogueiro, Tiago Bouça-Machado, Bernardo Sousa-Pinto and Hugo Santos-Sousa
J. Clin. Med. 2024, 13(11), 3320; https://doi.org/10.3390/jcm13113320
Full text available online: https://www.mdpi.com/2077-0383/13/11/3320

9. “Diagnostic, Theranostic and Prognostic Value of Thyroglobulin in Thyroid Cancer”
by Luca Giovanella, Federica D’Aurizio, Petra Petranović Ovčariček and Rainer Görges
J. Clin. Med. 2024, 13(9), 2463; https://doi.org/10.3390/jcm13092463
Full text available online: https://www.mdpi.com/2077-0383/13/9/2463

We are pleased to announce that the winner of the JCM 2024 Young Investigator Award is Dr. Gabriela Lima de Melo Ghisi.

Dr. Gabriela Lima de Melo Ghisi is a scientist at the University Health Network (UHN) in Canada, with a research focus on implementation of patient education interventions across different chronic disease settings and global access to chronic disease management. She holds adjunct professor positions at the University of Toronto and York University (Canada), UFMG (Brazil), and the University of Sydney (Australia). Dr. Ghisi has published over 160 peer-reviewed manuscripts. Ranked among the top three heart rehabilitation researchers globally (SciVal/Scopus 2019-2025), she also serves on the editorial boards of four leading medical journals.

Dr. Ghisi has led global initiatives to enhance cardiac health education, including developing and evaluating evidence-based patient education curricula in cardiac rehabilitation (CR) programs across 10 countries. She co-developed the first women-focused CR clinical practice guidelines and introduced tailored educational curricula in Canada.

Since 2016, Dr. Ghisi has held leadership roles with the International Council of Cardiovascular Prevention and Rehabilitation (ICCPR), part of the World Heart Federation (WHF), where she currently serves as Chair. Dr. Ghisi’s proven ability to translate research into practical tools and best practices has shaped CR delivery worldwide, positioning her as a global leader in the field and a key contributor to the success of this project.

Upon receiving this honour, Dr. Ghisi wanted to convey the following sentiments: “As someone who has dedicated much of my career to advancing cardiovascular prevention and rehabilitation, I believe that open access is essential for scientific progress. Coming from a middle-income country, I have seen firsthand how important it is to ensure that knowledge is accessible to all, regardless of geographic or financial constraints. Open access platforms like MDPI play a pivotal role in democratizing science, allowing researchers, clinicians, and patients alike to benefit from the latest evidence and innovations.

Being recognized by such a prestigious journal not only motivates me to continue my work, but it also reinforces the importance of collaborative, accessible science in improving global healthcare. I look forward to contributing to the ongoing dialogue and advancing cardiovascular care for patients worldwide”.

This is an outstanding achievement in today’s competitive academic environment. Please join us in congratulating Dr. Ghisi on her outstanding achievements.

As the awardee, Dr. Gabriela Lima de Melo Ghisi will receive the following honorarium:

• CHF 2000;
• An electronic certificate;
• A free voucher for article processing fees valid for one year.

We would like to thank all the nominators from various fields of study and all Award Committee Members for their evaluation of the many excellent nominations.

You can access more awards information via the following link: https://www.mdpi.com/journal/jcm/awards.

JCM Editorial Office